Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Investigation of Rs531564 Polymorphism in the Primary Microrna-124 Gene in Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis: Association With Disease Susceptibility and Clinical Characteristics Publisher Pubmed



Hassani M1 ; Dehani M1 ; Rafie MZ2 ; Esmaeilzadeh E3 ; Davar S4 ; Pakzad B5 ; Mosallaei M1 ; Hoseini SM6 ; Bayat H7, 8 ; Soosanabadi M9
Authors
Show Affiliations
Authors Affiliations
  1. 1. School of Medicine, Aja University of Medical Science, Tehran, Iran
  2. 2. School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
  3. 3. Fetal Health Research Center, Hope Generation Foundation, Tehran, Iran
  4. 4. Department of Epidemiology and Biostatistics, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran
  5. 5. Division of Rheumatology, Department of Internal Medicine, School of Medicine, Isfahan University of Medical Science, Isfahan, Iran
  6. 6. Department of Pediatric, Semnan University of Medical Sciences, Semnan, Iran
  7. 7. Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran
  8. 8. Medical Nano-Technology and Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  9. 9. Department of Medical Genetics, Semnan University of Medical Sciences, Semnan, Iran

Source: Iranian Journal of Allergy, Asthma and Immunology Published:2021


Abstract

MicroRNA-124 (miR-124) is known as an important regulator of the immune system and inflammatory response. Studies have reported that this miRNA is dysregulated in autoimmune disorders such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). A functional analysis demonstrated that rs531564 (C>G) affects the biogenesis of primary microRNA transcript-124 (pri-miR-124) and changes the expression of mature miR-124. In the present study, for the first time, we intended to evaluate the possible association between rs531564 polymorphism with SLE and RA risk. In this case-control study, 110 patients with SLE, 115 patients with RA, and 120 healthy subjects were enrolled to evaluate rs531564 genotypes with real-time polymerase chain reaction (PCR) high resolution melting method. Our findings demonstrated that frequency of GC genotype and G allele were considerably higher in the control group than RA patients, demonstrating that that GC genotype and G allele have a protective effect for healthy individuals (GC vs CC; OR: 0.29; 95%CI [0.12,0.67] and G vs C; OR: 0.42; 95%CI [0.23,0.78]). However, no significant correlation was confirmed between allele and genotype frequencies of rs531564 with SLE risk (p>0.05). However, the G allele in rs531564 polymorphism was associated with serum level of C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), anti-dsDNA antibody, C3, C4, and creatinine, and frequency of renal involvements in SLE patients (p<0.05). Moreover, in RA patients, the G was correlated with lower concentration ESR and CRP (p<0.001). Our findings propose a considerable association between rs531564 polymorphism in the pri-miR-124 gene with susceptibility and clinical characteristics of RA and SLE in the Iranian population. Copyright © 2021 Hassani et al.
Experts (# of related papers)
Other Related Docs